These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
204 related articles for article (PubMed ID: 20036592)
1. Human recombinant palmitoyl-protein thioesterase-1 (PPT1) for preclinical evaluation of enzyme replacement therapy for infantile neuronal ceroid lipofuscinosis. Lu JY; Hu J; Hofmann SL Mol Genet Metab; 2010 Apr; 99(4):374-8. PubMed ID: 20036592 [TBL] [Abstract][Full Text] [Related]
2. Intravenous high-dose enzyme replacement therapy with recombinant palmitoyl-protein thioesterase reduces visceral lysosomal storage and modestly prolongs survival in a preclinical mouse model of infantile neuronal ceroid lipofuscinosis. Hu J; Lu JY; Wong AM; Hynan LS; Birnbaum SG; Yilmaz DS; Streit BM; Lenartowicz EM; Thompson TC; Cooper JD; Hofmann SL Mol Genet Metab; 2012 Sep; 107(1-2):213-21. PubMed ID: 22704978 [TBL] [Abstract][Full Text] [Related]
3. Intrathecal enzyme replacement therapy improves motor function and survival in a preclinical mouse model of infantile neuronal ceroid lipofuscinosis. Lu JY; Nelvagal HR; Wang L; Birnbaum SG; Cooper JD; Hofmann SL Mol Genet Metab; 2015; 116(1-2):98-105. PubMed ID: 25982063 [TBL] [Abstract][Full Text] [Related]
4. Histochemical localization of palmitoyl protein thioesterase-1 activity. Dearborn JT; Ramachandran S; Shyng C; Lu JY; Thornton J; Hofmann SL; Sands MS Mol Genet Metab; 2016 Feb; 117(2):210-6. PubMed ID: 26597320 [TBL] [Abstract][Full Text] [Related]
5. Cln3-mutations underlying juvenile neuronal ceroid lipofuscinosis cause significantly reduced levels of Palmitoyl-protein thioesterases-1 (Ppt1)-protein and Ppt1-enzyme activity in the lysosome. Appu AP; Bagh MB; Sadhukhan T; Mondal A; Casey S; Mukherjee AB J Inherit Metab Dis; 2019 Sep; 42(5):944-954. PubMed ID: 31025705 [TBL] [Abstract][Full Text] [Related]
6. Synergistic effects of treating the spinal cord and brain in CLN1 disease. Shyng C; Nelvagal HR; Dearborn JT; Tyynelä J; Schmidt RE; Sands MS; Cooper JD Proc Natl Acad Sci U S A; 2017 Jul; 114(29):E5920-E5929. PubMed ID: 28673981 [TBL] [Abstract][Full Text] [Related]
7. A murine model of infantile neuronal ceroid lipofuscinosis-ultrastructural evaluation of storage in the central nervous system and viscera. Galvin N; Vogler C; Levy B; Kovacs A; Griffey M; Sands MS Pediatr Dev Pathol; 2008; 11(3):185-92. PubMed ID: 17990914 [TBL] [Abstract][Full Text] [Related]
9. The novel Cln1(R151X) mouse model of infantile neuronal ceroid lipofuscinosis (INCL) for testing nonsense suppression therapy. Miller JN; Kovács AD; Pearce DA Hum Mol Genet; 2015 Jan; 24(1):185-96. PubMed ID: 25205113 [TBL] [Abstract][Full Text] [Related]
10. CNS-directed AAV2-mediated gene therapy ameliorates functional deficits in a murine model of infantile neuronal ceroid lipofuscinosis. Griffey MA; Wozniak D; Wong M; Bible E; Johnson K; Rothman SM; Wentz AE; Cooper JD; Sands MS Mol Ther; 2006 Mar; 13(3):538-47. PubMed ID: 16364693 [TBL] [Abstract][Full Text] [Related]
11. Cln1-mutations suppress Rab7-RILP interaction and impair autophagy contributing to neuropathology in a mouse model of infantile neuronal ceroid lipofuscinosis. Sarkar C; Sadhukhan T; Bagh MB; Appu AP; Chandra G; Mondal A; Saha A; Mukherjee AB J Inherit Metab Dis; 2020 Sep; 43(5):1082-1101. PubMed ID: 32279353 [TBL] [Abstract][Full Text] [Related]
12. Pathogenesis and therapies for infantile neuronal ceroid lipofuscinosis (infantile CLN1 disease). Hawkins-Salsbury JA; Cooper JD; Sands MS Biochim Biophys Acta; 2013 Nov; 1832(11):1906-9. PubMed ID: 23747979 [TBL] [Abstract][Full Text] [Related]
13. Adeno-associated virus 2-mediated gene therapy decreases autofluorescent storage material and increases brain mass in a murine model of infantile neuronal ceroid lipofuscinosis. Griffey M; Bible E; Vogler C; Levy B; Gupta P; Cooper J; Sands MS Neurobiol Dis; 2004 Jul; 16(2):360-9. PubMed ID: 15193292 [TBL] [Abstract][Full Text] [Related]
14. Synergistic effects of central nervous system-directed gene therapy and bone marrow transplantation in the murine model of infantile neuronal ceroid lipofuscinosis. Macauley SL; Roberts MS; Wong AM; McSloy F; Reddy AS; Cooper JD; Sands MS Ann Neurol; 2012 Jun; 71(6):797-804. PubMed ID: 22368049 [TBL] [Abstract][Full Text] [Related]
15. Disruption of PPT1 or PPT2 causes neuronal ceroid lipofuscinosis in knockout mice. Gupta P; Soyombo AA; Atashband A; Wisniewski KE; Shelton JM; Richardson JA; Hammer RE; Hofmann SL Proc Natl Acad Sci U S A; 2001 Nov; 98(24):13566-71. PubMed ID: 11717424 [TBL] [Abstract][Full Text] [Related]
16. An anti-neuroinflammatory that targets dysregulated glia enhances the efficacy of CNS-directed gene therapy in murine infantile neuronal ceroid lipofuscinosis. Macauley SL; Wong AM; Shyng C; Augner DP; Dearborn JT; Pearse Y; Roberts MS; Fowler SC; Cooper JD; Watterson DM; Sands MS J Neurosci; 2014 Sep; 34(39):13077-82. PubMed ID: 25253854 [TBL] [Abstract][Full Text] [Related]
17. Inefficient cleavage of palmitoyl-protein thioesterase (PPT) substrates by aminothiols: implications for treatment of infantile neuronal ceroid lipofuscinosis. Lu JY; Hofmann SL J Inherit Metab Dis; 2006 Feb; 29(1):119-26. PubMed ID: 16601878 [TBL] [Abstract][Full Text] [Related]
18. Neuroprotection of host cells by human central nervous system stem cells in a mouse model of infantile neuronal ceroid lipofuscinosis. Tamaki SJ; Jacobs Y; Dohse M; Capela A; Cooper JD; Reitsma M; He D; Tushinski R; Belichenko PV; Salehi A; Mobley W; Gage FH; Huhn S; Tsukamoto AS; Weissman IL; Uchida N Cell Stem Cell; 2009 Sep; 5(3):310-9. PubMed ID: 19733542 [TBL] [Abstract][Full Text] [Related]
19. Combination small molecule PPT1 mimetic and CNS-directed gene therapy as a treatment for infantile neuronal ceroid lipofuscinosis. Roberts MS; Macauley SL; Wong AM; Yilmas D; Hohm S; Cooper JD; Sands MS J Inherit Metab Dis; 2012 Sep; 35(5):847-57. PubMed ID: 22310926 [TBL] [Abstract][Full Text] [Related]